Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study

BackgroundThe treatment of multisystem inflammatory syndrome in children unresponsive to first-line therapies (IVIG and/or steroids) is challenging. The effectiveness of IL-1 receptor antagonist, anakinra, is debated.Patients and methodsWe conducted an anonymous retrospective multicenter study on MI...

Full description

Bibliographic Details
Main Authors: Francesco Licciardi, Carlotta Covizzi, Marta Dellepiane, Nicole Olivini, Maria Vincenza Mastrolia, Andrea Lo Vecchio, Viviana Monno, Maria Tardi, Angela Mauro, Maria Alessio, Giovanni Filocamo, Marco Cattalini, Andrea Taddio, Roberta Caorsi, Gian Luigi Marseglia, Francesco La Torre, Andrea Campana, Gabriele Simonini, Angelo Ravelli, Davide Montin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pediatrics
Subjects:
MIS-C
multisystem inflammatory syndrome
pediatrics
COVID-19
SARS-CoV2
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1137051/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1137051/full

Similar Items